Insights - vaccine

Our charts and insights showcase our thought-leadership on key issues in macro research, geopolitical investment and investment strategy. Visit our research services and request a trial to find out more.


What is normal anyway? Our clients respond

22 Jan 2021 - Oliver Brennan

At our MacroFest virtual event on 12th and 13th January, we discussed the outlook for global growth, global markets, energy, deglobalization and, of course, COVID-19, among many other topics. As a follow-up to the.

#Inflation #Eurozone #Emerging Markets #Covid19 #Currencies #USD #Vaccine

The Vaccine Matrix: Winners and Losers

30 Nov 2020 - Oliver Brennan

Fill in the form below to download the full report - The Vaccine Matrix: Winners and Losers, by Oliver Brennan, Managing Director, Macro Strategy. What does the great rotation mean for countries’ economies? Is it simply.

#Eurozone #China #Vaccine #Recovery

EM: Vaccine rotation impact

17 Nov 2020 - Jon Harrison

The prospect of a vaccine will drive a rotation to underperforming EM assets at the expense of outperformers. EM exporters will benefit from rising global growth, while growing inflationary pressures will shift the.

#Emerging Markets #Vaccine

BioNTech/Pfizer vaccine announcement in a financial market perspective

13 Nov 2020 - Christopher Granville

“Where might be the catch?” This question about the prospects for the vaccine route to suppressing the pandemic arises naturally from financial markets’ acclamation of last Monday’s Pfizer/BioNTech announcement. Before.

#Fiscal Policy #Stimulus #Vaccine

The Fed's Shortened Timeline

12 Nov 2020 - Steven Blitz

The vaccine arrives early 2021, so our growth forecast accelerates as a result, beginning in 2021 Q3, and the timeline for when the Fed first “tightens” shortens. It may seem odd to relay this view just when the.

#Federal Reserve #Monetary Policy #US Economy #Vaccine #Quantitative Easing

VIDEO
Video

Video

View our summary videos on fast trending topics. To listen to a recording of our Conference Calls, please get in touch with zdl@tslombard.com

READ MORE
TRACK RECORD
Track Record

Track Record

We have a 30 year track record of successful calls. Many of these calls combined economic, political and market analysis.

READ MORE
PRESS
Press

Press

To request an interview with a member of our team, please get in touch zdl@tslombard.com .

READ MORE